A study has found that patients support using biomarkers to inform decisions in ovarian cancer treatment trials. The use of biomarkers in ovarian cancer treatment is an area of ongoing research, with studies examining their role in guiding therapy and improving outcomes. Other developments in ovarian cancer treatment are also being explored, including new therapies and approaches such as immunotherapy and robotic surgery.